David Carlos Rodriguez Jr. sent the woman nude photos over Snapchat during those eight months, when he wrote her 15 ...
The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out for its potency, but above all, in comparison with opioids, for its safety," ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Learn more› By Erin Roberts and Ben Keough After considering new apps, we still think that Adobe Lightroom and Snapseed are the best choices for editing photos when you’re away from a desktop ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Pictures of a frightened looking Robert Thompson and a nervous Jon Venables holding identification placards were first shown on a Channel 4 Despatches programme entitled 'Unforgiven' last week.
The number of opioid prescriptions has since decreased, and the current wave of the opioid epidemic is driven mainly by illegal fentanyl rather than prescription painkillers. Opioids reduce pain ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain.Journavx received FDA ...
Vertex Pharmaceuticals A new painkiller has been approved for the first time in 25 years — and there's no risk of addiction, experts say. On Thursday, Jan. 30, The U.S. Food and Drug ...
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators. Journavx, or suzetrigine ...
Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.